Hence, with all the data obtained it could be concluded that three seaweed compounds, BT012, RL074 and RL442, may act as a potential anti-obesity lead compound in targeting FTO. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.